-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Sector Perform on Pliant Therapeutics, Lowers Price Target to $2

Benzinga·11/07/2025 19:19:06
Listen to the news
RBC Capital analyst Brian Abrahams maintains Pliant Therapeutics (NASDAQ:PLRX) with a Sector Perform and lowers the price target from $3 to $2.